These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37667959)

  • 1. Telogen effluvium and COVID-19: a cross-sectional study.
    Aldahish A; Vasudevan R; Salem H; Alqahtani A; AlQasim S; Alqhatani A; Al Shahrani M; Al Mohsen L; Hajla M; Calina D; Sharifi-Rad J
    Eur Rev Med Pharmacol Sci; 2023 Aug; 27(16):7823-7830. PubMed ID: 37667959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 induced telogen effluvium.
    Aksoy H; Yıldırım UM; Ergen P; Gürel MS
    Dermatol Ther; 2021 Nov; 34(6):e15175. PubMed ID: 34708909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 infection is a major cause of acute telogen effluvium.
    Sharquie KE; Jabbar RI
    Ir J Med Sci; 2022 Aug; 191(4):1677-1681. PubMed ID: 34467470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of patients with telogen effluvium during the pandemic: May the monocytes be responsible for post COVID-19 telogen effluvium?
    Koç Yıldırım S; Erbağcı E; Demirel Öğüt N
    J Cosmet Dermatol; 2022 May; 21(5):1809-1815. PubMed ID: 35201647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
    Hussain N; Agarwala P; Iqbal K; Omar HMS; Jangid G; Patel V; Rathore SS; Kumari C; Velasquez-Botero F; López GAB; Vishwakarma Y; Nipu AP; Ahmed NK
    J Med Virol; 2022 Apr; 94(4):1391-1401. PubMed ID: 34931698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telogen effluvium associated with COVID-19 infection.
    Olds H; Liu J; Luk K; Lim HW; Ozog D; Rambhatla PV
    Dermatol Ther; 2021 Mar; 34(2):e14761. PubMed ID: 33405302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association Between Hair Loss and COVID-19: The Impact of Hair Loss After COVID-19 Infection on the Quality of Life Among Residents in Saudi Arabia.
    Alkeraye S; Alrashidi A; Alotaibi NS; Almajli N; Alkhalifah B; Bajunaid N; Alharthi R; AlKaff T; Alharbi K
    Cureus; 2022 Oct; 14(10):e30266. PubMed ID: 36381793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of telogen effluvium hair loss in COVID-19 patients and its relationship with disease severity.
    Seyfi S; Alijanpour R; Aryanian Z; Ezoji K; Mahmoudi M
    J Med Life; 2022 May; 15(5):631-634. PubMed ID: 35815081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia.
    Abdulwahab RA; Aldajani BM; Natto NK; Janabi AM; Alhijaili OI; Faqih NT; Alharbi A
    Cureus; 2022 Sep; 14(9):e29285. PubMed ID: 36277546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of QR678 Neo
    Shome D; Kapoor R; Surana M; Vadera S; Shah R
    J Cosmet Dermatol; 2022 Jan; 21(1):16-23. PubMed ID: 34875139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of autologous micrografts injection from the scalp tissue in the treatment of COVID-19 associated telogen effluvium: Clinical and trichoscopic evaluation.
    Hawwam SA; Ismail M; Elhawary EE
    Dermatol Ther; 2022 Jul; 35(7):e15545. PubMed ID: 35486375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Review of the post-COVID-19 syndrome associated to acute telogen effluvium].
    Chávez-Chavira G
    Rev Med Inst Mex Seguro Soc; 2023 Jul; 61(4):496-501. PubMed ID: 37540705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telogen effluvium related to post severe Sars-Cov-2 infection: Clinical aspects and our management experience.
    Rizzetto G; Diotallevi F; Campanati A; Radi G; Bianchelli T; Molinelli E; Mazzanti S; Offidani A
    Dermatol Ther; 2021 Jan; 34(1):e14547. PubMed ID: 33190397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19-induced hair shedding and related risk factors: A Saudi perspective.
    Bukhari AE; AlDosari DA; AlDosari MA; Muqrin RF; Moazin OM; Almutlq MM; Altalhab SM; Alharithy RS; Alkhalifah AI
    J Family Med Prim Care; 2023 Dec; 12(12):3304-3311. PubMed ID: 38361868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study.
    Awad NEHA; Obaid ZM; Zaky MS; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):761-767. PubMed ID: 37704885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia.
    Gerkowicz A; Bartosińska J; Krakowski P; Karpiński R; Krasowska D; Raczkiewicz D; Kwasny M; Krasowska D
    Ann Agric Environ Med; 2024 Jun; 31(2):239-247. PubMed ID: 38940108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hair loss after severe acute respiratory syndrome coronavirus 2 infection: Insight into the pathophysiology with implication for better management.
    Ohyama M; Matsudo K; Fujita T
    J Dermatol; 2022 Oct; 49(10):939-947. PubMed ID: 35633047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia.
    Guarnieri G; Bertagna De Marchi L; Marcon A; Panunzi S; Batani V; Caminati M; Furci F; Senna G; Alaibac M; Vianello A
    Ann Med; 2022 Dec; 54(1):869-874. PubMed ID: 35341398
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19-associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study.
    Damevska K; Sotirovski T; Batkoska B; Djambazova M; Radeski V; Simonoska J; Bachevski D; Rushiti Mehmeti K; Popovski T; Labenishta E; Ristovski A; Najdova A
    Acta Dermatovenerol Croat; 2024 Mar; 32(1):33-38. PubMed ID: 38946185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-COVID Telogen Effluvium.
    Tešanović Perković D; Vukojević M; Bukvić Mokos Z
    Acta Dermatovenerol Croat; 2022 Dec; 30(4):220-226. PubMed ID: 36919388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.